The second affiliated hospital Zhejiang university school of medicine
Hangzhou, Zhejiang 310014
4 studies enrolling now · 12 studies all time
What they study most
Advanced Solid Tumors, Cardiovascular Diseases, Coronary Artery Disease, Coronary Disease, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Giant Cell Tumor of Tendon Sheath, HER2-positive Breast Cancer, Heart Diseases, Kidney Disease, Limited-Stage Small Cell Lung Cancer, Metastatic Breast Cancer
Studies at this site
- A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) — Recruiting now
- A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy — Recruiting now
- Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns — Recruiting now
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor — Recruiting now
- A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
- Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early
- Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed
- Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) — Running, not enrolling
- A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer — Running, not enrolling
- Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer — Running, not enrolling
- A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors — Completed
- International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) — Completed